These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11508069)

  • 1. Primary drug resistance pattern of mycobacterium tuberculosis in Dhaka, Bangladesh.
    Miah MR; Ali MS; Saleh AA; Sattar H
    Bangladesh Med Res Counc Bull; 2000 Aug; 26(2):33-40. PubMed ID: 11508069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on Mycobacterium tuberculosis: the primary drug resistance pattern.
    Siddique MA; Rahman KM; Muazzam N; Hossain T; Islam KM; Rahman MA; Chowdhury FA; Ali CM
    Bangladesh Med Res Counc Bull; 1995 Apr; 21(1):18-23. PubMed ID: 7575339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug susceptibility pattern of Mycobacterium tuberculosis isolates against conventional anti-tuberculosis drugs in Dhaka, Bangladesh.
    Mottalib A; Hossain M; Khalil I; Islam S; Hossain A
    Saudi Med J; 2011 May; 32(5):484-8. PubMed ID: 21556469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance of Mycobacterium tuberculosis in selected urban and rural areas in Bangladesh.
    Zaman K; Rahim Z; Yunus M; Arifeen S; Baqui A; Sack D; Hossain S; Banu S; Islam MA; Ahmed J; Breiman R; Black R
    Scand J Infect Dis; 2005; 37(1):21-6. PubMed ID: 15764186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs.
    Abate G; Miörner H; Ahmed O; Hoffner SE
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):580-4. PubMed ID: 9661826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
    Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
    Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
    Moniruzzaman A; Elwood RK; Schulzer M; FitzGerald JM
    Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.
    Asmamaw D; Seyoum B; Makonnen E; Atsebeha H; Woldemeskel D; Yamuah L; Addus H; Aseffa A
    Ethiop Med J; 2008 Oct; 46(4):367-74. PubMed ID: 19271401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nationwide study of drug resistance among acid-fast bacilli positive pulmonary tuberculosis cases in Lebanon.
    Araj GF; Saade M; Itani LY
    Int J Tuberc Lung Dis; 2006 Jan; 10(1):63-7. PubMed ID: 16466039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
    Ratsirahonana O; Rasolofo Razanamparany V; Rasolonavalona T; Rakotonirina V; Rakotoarisaonina A; Rakotoherisoa A; Ralamboson M; Cauchoix B; Rakotondramarina D; Ramarokoto H
    Arch Inst Pasteur Madagascar; 2002; 68(1-2):44-7. PubMed ID: 12643091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
    Al-Marri MR
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
    Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifampicin mono-resistant Mycobacterium tuberculosis in Bujumbura, Burundi: results of a drug resistance survey.
    Sanders M; Van Deun A; Ntakirutimana D; Masabo JP; Rukundo J; Rigouts L; Fissette K; Portaelst F
    Int J Tuberc Lung Dis; 2006 Feb; 10(2):178-83. PubMed ID: 16499257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A community-based TB drug susceptibility study in Mimika District, Papua Province, Indonesia.
    Kelly PM; Ardian M; Waramori G; Anstey NM; Syahrial H; Tjitra E; Bastian I; Maguire GP; Lumb R
    Int J Tuberc Lung Dis; 2006 Feb; 10(2):167-71. PubMed ID: 16499255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial resistance to antituberculosis drugs in Yaounde, Cameroon in 1995.
    Bercion R; Kuaban C
    Int J Tuberc Lung Dis; 1997 Apr; 1(2):110-4. PubMed ID: 9441073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characterization of the drug resistance spectrum of rifampicin-resistant M. tuberculosis to other first-line antituberculous drugs].
    Isakova ZhT; Goncharova ZK; Aldashev AA
    Probl Tuberk Bolezn Legk; 2008; (11):39-42. PubMed ID: 19140379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.